Satellos Bioscience Stock Net Income
| MSCL Stock | 16.88 0.89 5.57% |
As of the 3rd of February, Satellos Bioscience has the Semi Deviation of 4.03, risk adjusted performance of 0.1485, and Coefficient Of Variation of 523.77. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Satellos Bioscience, as well as the relationship between them.
Satellos Bioscience's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Satellos Bioscience's valuation are provided below:We have found one hundred ten available fundamental trend indicators for Satellos Bioscience, which can be analyzed and compared to other ratios and to its competition. Self-guided Investors are advised to double-check Satellos Bioscience's current fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 3rd of February 2026, Market Cap is likely to drop to about 8.6 M. In addition to that, Enterprise Value is likely to drop to about 6.5 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -25.3 M | -24 M | |
| Net Loss | -18.4 M | -19.3 M | |
| Net Loss | (0.36) | (0.38) | |
| Net Income Per E B T | 0.90 | 0.75 |
Satellos | Net Income |
Evaluating Satellos Bioscience's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Satellos Bioscience's fundamental strength.
Latest Satellos Bioscience's Net Income Growth Pattern
Below is the plot of the Net Income of Satellos Bioscience over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Satellos Bioscience financial statement analysis. It represents the amount of money remaining after all of Satellos Bioscience operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Satellos Bioscience's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Satellos Bioscience's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (28.1 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Satellos Net Income Regression Statistics
| Arithmetic Mean | (8,328,967) | |
| Coefficient Of Variation | (115.86) | |
| Mean Deviation | 8,253,599 | |
| Median | (1,988,452) | |
| Standard Deviation | 9,650,329 | |
| Sample Variance | 93.1T | |
| Range | 26.5M | |
| R-Value | (0.82) | |
| Mean Square Error | 31.9T | |
| R-Squared | 0.68 | |
| Significance | 0.000047 | |
| Slope | (1,575,064) | |
| Total Sum of Squares | 1490.1T |
Satellos Net Income History
Satellos Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Satellos Bioscience is extremely important. It helps to project a fair market value of Satellos Stock properly, considering its historical fundamentals such as Net Income. Since Satellos Bioscience's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Satellos Bioscience's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Satellos Bioscience's interrelated accounts and indicators.
Click cells to compare fundamentals
Satellos Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Satellos Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Satellos Bioscience.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Satellos Bioscience on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Satellos Bioscience or generate 0.0% return on investment in Satellos Bioscience over 90 days. Satellos Bioscience is related to or competes with Biosyent, Cardiol Therapeutics, Cannara Biotech, Quipt Home, Sernova Corp, Helix BioPharma, and Medicenna Therapeutics. Satellos Bioscience is entity of Canada. It is traded as Stock on TO exchange. More
Satellos Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Satellos Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Satellos Bioscience upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.63 | |||
| Information Ratio | 0.1798 | |||
| Maximum Drawdown | 22.79 | |||
| Value At Risk | (5.32) | |||
| Potential Upside | 9.23 |
Satellos Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Satellos Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Satellos Bioscience's standard deviation. In reality, there are many statistical measures that can use Satellos Bioscience historical prices to predict the future Satellos Bioscience's volatility.| Risk Adjusted Performance | 0.1485 | |||
| Jensen Alpha | 0.9544 | |||
| Total Risk Alpha | 0.6337 | |||
| Sortino Ratio | 0.1947 | |||
| Treynor Ratio | (5.40) |
Satellos Bioscience February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1485 | |||
| Market Risk Adjusted Performance | (5.39) | |||
| Mean Deviation | 3.86 | |||
| Semi Deviation | 4.03 | |||
| Downside Deviation | 4.63 | |||
| Coefficient Of Variation | 523.77 | |||
| Standard Deviation | 5.01 | |||
| Variance | 25.09 | |||
| Information Ratio | 0.1798 | |||
| Jensen Alpha | 0.9544 | |||
| Total Risk Alpha | 0.6337 | |||
| Sortino Ratio | 0.1947 | |||
| Treynor Ratio | (5.40) | |||
| Maximum Drawdown | 22.79 | |||
| Value At Risk | (5.32) | |||
| Potential Upside | 9.23 | |||
| Downside Variance | 21.41 | |||
| Semi Variance | 16.28 | |||
| Expected Short fall | (4.70) | |||
| Skewness | 0.2132 | |||
| Kurtosis | 0.4823 |
Satellos Bioscience Backtested Returns
Satellos Bioscience is somewhat reliable given 3 months investment horizon. Satellos Bioscience owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.26, which indicates the firm had a 0.26 % return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.25% are justified by taking the suggested risk. Use Satellos Bioscience Risk Adjusted Performance of 0.1485, coefficient of variation of 523.77, and Semi Deviation of 4.03 to evaluate company specific risk that cannot be diversified away. Satellos Bioscience holds a performance score of 20 on a scale of zero to a hundred. The entity has a beta of -0.18, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Satellos Bioscience are expected to decrease at a much lower rate. During the bear market, Satellos Bioscience is likely to outperform the market. Use Satellos Bioscience maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to analyze future returns on Satellos Bioscience.
Auto-correlation | -0.61 |
Very good reverse predictability
Satellos Bioscience has very good reverse predictability. Overlapping area represents the amount of predictability between Satellos Bioscience time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Satellos Bioscience price movement. The serial correlation of -0.61 indicates that roughly 61.0% of current Satellos Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.61 | |
| Spearman Rank Test | -0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 8.32 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Satellos Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Satellos Bioscience reported net income of (28.1 Million). This is 108.23% lower than that of the Healthcare sector and 140.12% lower than that of the Biotechnology industry. The net income for all Canada stocks is 104.92% higher than that of the company.
Satellos Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Satellos Bioscience's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Satellos Bioscience could also be used in its relative valuation, which is a method of valuing Satellos Bioscience by comparing valuation metrics of similar companies.Satellos Bioscience is currently under evaluation in net income category among its peers.
Satellos Fundamentals
| Return On Equity | -0.88 | ||||
| Return On Asset | -0.54 | ||||
| Current Valuation | 186.87 M | ||||
| Shares Outstanding | 15.46 M | ||||
| Shares Owned By Insiders | 8.30 % | ||||
| Shares Owned By Institutions | 8.20 % | ||||
| Number Of Shares Shorted | 20.46 K | ||||
| Price To Book | 5.06 X | ||||
| Gross Profit | (16.68 M) | ||||
| EBITDA | (28.08 M) | ||||
| Net Income | (28.1 M) | ||||
| Cash And Equivalents | 40.07 M | ||||
| Total Debt | 5.16 M | ||||
| Book Value Per Share | 2.98 X | ||||
| Cash Flow From Operations | (24.98 M) | ||||
| Short Ratio | 1.16 X | ||||
| Earnings Per Share | 3.48 X | ||||
| Target Price | 20.82 | ||||
| Number Of Employees | 14 | ||||
| Beta | 0.71 | ||||
| Market Capitalization | 239.15 M | ||||
| Total Asset | 73.02 M | ||||
| Retained Earnings | (75.6 M) | ||||
| Net Asset | 73.02 M |
About Satellos Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Satellos Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Satellos Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Satellos Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Satellos Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Satellos Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Satellos Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving together with Satellos Stock
Moving against Satellos Stock
The ability to find closely correlated positions to Satellos Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Satellos Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Satellos Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Satellos Bioscience to buy it.
The correlation of Satellos Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Satellos Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Satellos Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Satellos Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Satellos Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.